The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Vasculitis, pulmonary (w/wo AH), extrapulmonary, systemic: ANCA-positive
Publications
Systemic p-ANCA vasculitis with fatal outcome, arising in the setting of methimazole use.
Clinical nephrology. Case studies 2019;7;23-26 — 2019 — 23-26
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use.
Case reports in endocrinology 2015;2015;530319 — 2015 — 530319
ANCA-associated vasculitis with central retinal artery occlusion developing during treatment with methimazole.
Internal medicine (Tokyo, Japan) 2012;51;3177-80 — 2012 — 3177-80
PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect?
Rheumatology international 2013 Jan;33;117-20 — 2013 Jan — 117-20
Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2010 May-Jun;16;449-51 — 2010 May-Jun — 449-51
Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Arthritis research & therapy 2005;7;R1072-81 — 2005 — R1072-81